Clinical trials in Guam
37 studies list at least one site in Guam. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-24.
Status
- Active, not recruiting
- 18
- Completed
- 8
- Recruiting
- 5
- Terminated
- 3
- No longer available
- 2
- Enrolling by invitation
- 1
Phase
- Phase 3
- 11
- Phase 2
- 9
Most studied here
Who runs them
National Cancer Institute (NCI) (9) · SWOG Cancer Research Network (8) · Alliance for Clinical Trials in Oncology (7) · Wake Forest University Health Sciences (5) · ECOG-ACRIN Cancer Research Group (3) · U.S. Army Medical Research and Development Command (2) · University of Guam (2) · WestCare Pacific Islands, Inc. (1)
Studies
Recruiting first, then most recently updated. Showing 37 of 37 — search for more.
- Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])RecruitingNCT04267848Phase 3
- Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment DelaysRecruitingNCT07283939Not applicable
- Understanding and Enhancing Health-Related Social Needs (HRSN) Screening Among Community Oncology PracticesEnrolling by invitationNCT06412029
- Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid TumorsRecruitingNCT04871542
- S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast CancerRecruitingNCT03723928Not applicable
- Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer SurvivorsRecruitingNCT07018869Phase 3
- Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)Active, not recruitingNCT02194738Not applicable
- Increasing Patients' Engagement in Breast Cancer Surgery Decision-MakingActive, not recruitingNCT03766009Not applicable
- Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung CancerActive, not recruitingNCT03793179Phase 3
- Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue SarcomaActive, not recruitingNCT04339738Phase 2
- Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung CancerActive, not recruitingNCT04092283Phase 3
- Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)Active, not recruitingNCT06295367Not applicable
- To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close MonitoringActive, not recruitingNCT04597359Phase 2
- Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation TherapyTerminatedNCT02927249Phase 3
- Breast Cancer WEight Loss Study (BWEL Study)Active, not recruitingNCT02750826Phase 3
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Active, not recruitingNCT02465060Phase 2
- Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial CancerActive, not recruitingNCT03244384Phase 3
- Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder CancerActive, not recruitingNCT04164082Phase 2
- An Internet-based Program to Help Cancer Survivors Manage PainActive, not recruitingNCT04462302Not applicable
- Nivolumab and Ipilimumab in Treating Patients With Rare TumorsActive, not recruitingNCT02834013Phase 2
- Testing a School-Based E-cigarette, Tobacco, and Betel (Areca) Nut Use Prevention Curriculum for Guam YouthsCompletedNCT05037656Not applicable
- Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)Active, not recruitingNCT04496739Not applicable
- Testing Ramipril to Prevent Memory Loss in People With GlioblastomaCompletedNCT03475186Phase 2
- A Study of miRNA 371 in Patients With Germ Cell TumorsActive, not recruitingNCT04435756
- Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal CancerActive, not recruitingNCT04137107Phase 2/3
- Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)Active, not recruitingNCT02201992Phase 3
- Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)Active, not recruitingNCT04625647Phase 2
- Effect of Treatment on Work Experience in Patients With Stage I-III Prostate CancerCompletedNCT03963739
- Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic ChemotherapyCompletedNCT03578081Phase 3
- Evaluation of Mammographic Breast Density in Participants with Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502TerminatedNCT03609021
- Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid TumorsTerminatedNCT03887702Phase 3
- Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer SurvivorsCompletedNCT04205955Phase 2
- Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP)No longer availableNCT04360486
- Work Ability in Young Adult Cancer SurvivorsCompletedNCT03148080
- Expanded Access Remdesivir (RDV; GS-5734™)No longer availableNCT04302766
- Testing the Effectiveness of a Betel Nut Cessation ProgramCompletedNCT02942745Not applicable
- Guam Healthy Relationships Education ProgramCompletedNCT03790761Not applicable